Display options
Cite
Sinnott C, Byrne M, Bradley CP. Improving medication management for patients with multimorbidity in primary care: a qualitative feasibility study of the MY COMRADE implementation intervention. Pilot Feasibility Stud. 2017;3:14doi: 10.1186/s40814-017-0129-8.
Sinnott, C., Byrne, M., & Bradley, C. P. (2017). Improving medication management for patients with multimorbidity in primary care: a qualitative feasibility study of the MY COMRADE implementation intervention. Pilot and feasibility studies, 314. https://doi.org/10.1186/s40814-017-0129-8
Sinnott, Carol, et al. "Improving medication management for patients with multimorbidity in primary care: a qualitative feasibility study of the MY COMRADE implementation intervention." Pilot and feasibility studies vol. 3 (2017): 14. doi: https://doi.org/10.1186/s40814-017-0129-8
Sinnott C, Byrne M, Bradley CP. Improving medication management for patients with multimorbidity in primary care: a qualitative feasibility study of the MY COMRADE implementation intervention. Pilot Feasibility Stud. 2017 Mar 20;3:14. doi: 10.1186/s40814-017-0129-8. eCollection 2017. PMID: 28331631; PMCID: PMC5357807.
Copy Download .nbib Format: NLM
Share it on

Pilot Feasibility Stud. 2017 Mar 20;3:14. doi: 10.1186/s40814-017-0129-8. eCollection 2017.

Improving medication management for patients with multimorbidity in primary care: a qualitative feasibility study of the MY COMRADE implementation intervention.

Pilot and feasibility studies

Carol Sinnott, Molly Byrne, Colin P Bradley

Affiliations

  1. Department of General Practice, Western Gateway Building, University College Cork, Cork, Ireland.
  2. Health Behaviour Change Research Group, School of Psychology, National University of Ireland, Galway, Ireland.

PMID: 28331631 PMCID: PMC5357807 DOI: 10.1186/s40814-017-0129-8

Abstract

BACKGROUND: For the majority of patients with multimorbidity, the prescription of multiple long-term medications (polypharmacy) is indicated. However, polypharmacy poses a risk of adverse drug events, drug interactions and excessive treatment burdens. To help general practitioners (GPs) conduct more comprehensive medication reviews for patients with multimorbidity, we developed the theoretically-informed MultimorbiditY COllaborative Medication Review And DEcision Making (MY COMRADE) implementation intervention. In this study, we assessed the feasibility and acceptability of MY COMRADE by GPs.

METHODS: A non-randomised feasibility study using a qualitative framework approach was conducted. General practices were recruited by purposively sampling from interested GPs attending continuing professional development meetings (CPD) in southwest Ireland. Participating practices were instructed on the MY COMRADE implementation intervention which has five components: (i) action planning; (ii) allocation of protected time; (iii) peer-supported medication review; (iv) use of a prescribing checklist and (v) self-incentives (allocation of CPD points). GPs in participating practices agreed to conduct medication reviews on multimorbid patients from their own caseload using the MY COMRADE approach. After completing these reviews, qualitative interviews were conducted to evaluate GPs' experiences of the intervention and were analysed using the framework method.

RESULTS: GPs from ten practices participated in the study. The GPs reported that MY COMRADE was an acceptable approach to implementing medication review in general practice, especially for complex patients with multimorbidity. Action plans for the medication reviews varied between practices, but all reviews led to recommendations for optimising medications and patient safety. Many GPs felt that using the MY COMRADE approach would ultimately lead to more efficient use of their time, but a minority felt that the time and cost implications of using two GPs to review medications would not be sustainable unless greater incentives were used.

CONCLUSIONS: This study demonstrates that MY COMRADE is an acceptable and feasible approach to supporting comprehensive medication reviews for patients with multimorbidity. These findings indicate that a large scale trial of the effectiveness of MY COMRADE is now required to fully evaluate its potential to change prescribing behaviour and improve downstream outcomes such as prescribing appropriateness and treatment burden.

TRIAL REGISTRATION: ISRCTN registry: ISRCTN34837446.

References

  1. BMJ. 2004 Jun 26;328(7455):1561-3 - PubMed
  2. J Clin Epidemiol. 1998 May;51(5):367-75 - PubMed
  3. Br J Gen Pract. 2007 Jul;57(540):574-6 - PubMed
  4. PLoS One. 2016 Mar 15;11(3):e0150205 - PubMed
  5. Cochrane Database Syst Rev. 2014 Oct 07;(10):CD008165 - PubMed
  6. BMJ. 2013 Nov 20;347:f6753 - PubMed
  7. J Am Geriatr Soc. 2012 Oct;60(10):1957-68 - PubMed
  8. Implement Sci. 2006 Feb 23;1:5 - PubMed
  9. Eur J Clin Pharmacol. 2014 May;70(5):599-606 - PubMed
  10. BMJ. 2014 Jun 13;348:g3725 - PubMed
  11. Milbank Q. 2005;83(3):457-502 - PubMed
  12. JMIR Med Inform. 2015 Jan 07;3(1):e4 - PubMed
  13. Br J Clin Pharmacol. 2014 Oct;78(4):738-47 - PubMed
  14. Adm Policy Ment Health. 2011 Mar;38(2):65-76 - PubMed
  15. Br J Gen Pract. 2012 Jul;62(600):e503-10 - PubMed
  16. BMJ Open. 2013 Sep 13;3(9):e003610 - PubMed
  17. J Eval Clin Pract. 2008 Apr;14(2):185-90 - PubMed
  18. Pharmacoepidemiol Drug Saf. 2009 Sep;18(9):763-9 - PubMed
  19. Implement Sci. 2015 Sep 24;10:132 - PubMed
  20. BMJ. 2008 Sep 29;337:a1655 - PubMed
  21. J Gen Intern Med. 2007 Feb;22(2):246-52 - PubMed
  22. BMJ. 2004 Aug 21;329(7463):434 - PubMed
  23. Fam Pract. 2011 Oct;28(5):579-87 - PubMed
  24. Implement Sci. 2012 Apr 24;7:38 - PubMed
  25. J Clin Epidemiol. 2005 Feb;58(2):113-6; discussion 117-20 - PubMed
  26. Eur J Clin Pharmacol. 2014 May;70(5):575-81 - PubMed
  27. Lancet. 2007 Jul 14;370(9582):173-84 - PubMed
  28. Br J Gen Pract. 2015 Mar;65(632):e184-91 - PubMed
  29. BMJ. 2011 Jun 23;342:d3693 - PubMed

Publication Types